NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 107 filers reported holding NGM BIOPHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.00 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,147,000 | +390.2% | 54,550 | +360.1% | 0.03% | +357.1% |
| Q2 2021 | $234,000 | -33.0% | 11,855 | -1.2% | 0.01% | -36.4% |
| Q1 2021 | $349,000 | -3.9% | 12,000 | 0.0% | 0.01% | -8.3% |
| Q4 2020 | $363,000 | +90.1% | 12,000 | 0.0% | 0.01% | +50.0% |
| Q3 2020 | $191,000 | -25.7% | 12,000 | -7.7% | 0.01% | -38.5% |
| Q2 2020 | $257,000 | +60.6% | 13,000 | 0.0% | 0.01% | +18.2% |
| Q1 2020 | $160,000 | -33.3% | 13,000 | 0.0% | 0.01% | -21.4% |
| Q4 2019 | $240,000 | – | 13,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 3,766,666 | $59,928,000 | 49.90% |
| Greenspring Associates, LLC | 1,573,357 | $25,032,000 | 38.95% |
| Svennilson Peter | 18,017,932 | $286,665,000 | 23.39% |
| Aquilo Capital Management, LLC | 1,018,334 | $16,202,000 | 1.72% |
| Jasper Ridge Partners, L.P. | 308,750 | $4,912,000 | 0.28% |
| Samsara BioCapital, LLC | 36,451 | $580,000 | 0.16% |
| Rock Springs Capital Management LP | 360,454 | $5,735,000 | 0.15% |
| Point72 Asset Management, L.P. | 1,611,850 | $25,645,000 | 0.13% |
| Virtus ETF Advisers LLC | 14,880 | $237,000 | 0.12% |
| WELD CAPITAL MANAGEMENT LLC | 15,238 | $242,000 | 0.10% |